4//SEC Filing
Kanes Stephen 4
Accession 0001562180-21-006596
CIK 0001597553other
Filed
Oct 20, 8:00 PM ET
Accepted
Oct 21, 4:02 PM ET
Size
8.6 KB
Accession
0001562180-21-006596
Insider Transaction Report
Form 4
Kanes Stephen
Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2021-10-19$40.29/sh−1,120$45,125→ 13,471 total - Award
Common Stock
2021-10-19+3,800→ 14,591 total
Footnotes (1)
- [F1]On February 13, 2019, the reporting person was granted Performance Stock Units (PSUs) to acquire a total of 9,500 shares of common stock. The PSUs vest upon the achievement of certain milestones, one of which was met on October 19, 2021, resulting in the vesting of the PSUs as to 3,800 shares.
Issuer
Sage Therapeutics, Inc.
CIK 0001597553
Entity typeother
Related Parties
1- filerCIK 0001612859
Filing Metadata
- Form type
- 4
- Filed
- Oct 20, 8:00 PM ET
- Accepted
- Oct 21, 4:02 PM ET
- Size
- 8.6 KB